These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37586180)

  • 1. ANKRD22 knockdown suppresses papillary thyroid cell carcinoma growth and migration and modulates the Wnt/β-catenin signaling pathway.
    Wu Y; Chen W; Zhang B; Liu H
    Tissue Cell; 2023 Oct; 84():102193. PubMed ID: 37586180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
    Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S
    Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SDC4 Gene Silencing Favors Human Papillary Thyroid Carcinoma Cell Apoptosis and Inhibits Epithelial Mesenchymal Transition
    Chen LL; Gao GX; Shen FX; Chen X; Gong XH; Wu WJ
    Mol Cells; 2018 Sep; 41(9):853-867. PubMed ID: 30165731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KCNIP3 silence promotes proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma through activating Wnt/β-catenin pathway.
    Zhong J; Lin R; Wang G; Lin L; Ruan S; Liu W
    Tissue Cell; 2022 Apr; 75():101739. PubMed ID: 35066335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel LncRNA AK023507 inhibits cell metastasis and proliferation in Papillary Thyroid Cancer through β-catenin/Wnt Signaling Pathway.
    Yang M; Huang S; Zhao Y; Xie B; Hu X; Cai Y
    Biochem Biophys Res Commun; 2023 May; 655():104-109. PubMed ID: 36934585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of TRIM44 inhibits the proliferation and invasion in papillary thyroid cancer cells through suppressing the Wnt/β-catenin signaling pathway.
    Zhou Z; Liu Y; Ma M; Chang L
    Biomed Pharmacother; 2017 Dec; 96():98-103. PubMed ID: 28965013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of CSN6 attenuates papillary thyroid carcinoma progression by reducing Wnt/β-catenin signaling and sensitizes cancer cells to FH535 therapy.
    Wen D; Liao T; Ma B; Qu N; Shi RL; Lu ZW; Wang YL; Wei WJ; Ji QH
    Cancer Med; 2018 Feb; 7(2):285-296. PubMed ID: 29341469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXE1 supports the tumor promotion of Gli2 on papillary thyroid carcinoma by the Wnt/β-catenin pathway.
    Ma J; Huang X; Li Z; Shen Y; Lai J; Su Q; Zhao J; Xu J
    J Cell Physiol; 2019 Aug; 234(10):17739-17748. PubMed ID: 30793770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOX18 exerts tumor-suppressive functions in papillary thyroid carcinoma through inhibition of Wnt/β-catenin signaling.
    Geng Q; Deng H; Fu J; Cui F
    Exp Cell Res; 2020 Nov; 396(1):112249. PubMed ID: 32858034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular RNA Pvt1 oncogene (CircPVT1) promotes the progression of papillary thyroid carcinoma by activating the Wnt/β-catenin signaling pathway and modulating the ratio of microRNA-195 (miR-195) to vascular endothelial growth factor A (VEGFA) expression.
    Zeng L; Yuan S; Zhou P; Gong J; Kong X; Wu M
    Bioengineered; 2021 Dec; 12(2):11795-11810. PubMed ID: 34927541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA FALEC promotes proliferation, migration, and invasion of PTC cells through regulating Wnt/β-catenin signaling pathway.
    Xiao X; Li L; Cui JC; Wang Y
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4361-4367. PubMed ID: 32373973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3) inhibits proliferation and invasion of glioma cells by suppressing the Wnt/β-catenin signaling pathway.
    Xia S; Ji R; Zhan W
    BMC Neurol; 2017 Feb; 17(1):30. PubMed ID: 28187755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXN3 suppresses the growth and invasion of papillary thyroid cancer through the inactivation of Wnt/β-catenin pathway.
    Zhao C; Mo L; Li C; Han S; Zhao W; Liu L
    Mol Cell Endocrinol; 2020 Sep; 515():110925. PubMed ID: 32619584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of FHL1 suppresses papillary thyroid cancer proliferation and progression via inhibiting Wnt/β-catenin pathway.
    Chen J; Zeng C; Jin J; Zhang P; Zhang Y; Zhang H; Li Y; Guan H
    Endocrine; 2024 Jul; 85(1):238-249. PubMed ID: 38191984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taraxasterol inhibits TGF-β1-induced epithelial-to-mesenchymal transition in papillary thyroid cancer cells through regulating the Wnt/β-catenin signaling.
    Zhu J; Li X; Zhang S; Liu J; Yao X; Zhao Q; Kou B; Han P; Wang X; Bai Y; Zheng Z; Xu C
    Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S87-S95. PubMed ID: 34219514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ANKRD22 enhances breast cancer cell malignancy by activating the Wnt/β-catenin pathway via modulating NuSAP1 expression.
    Wu Y; Liu H; Gong Y; Zhang B; Chen W
    Bosn J Basic Med Sci; 2021 Jun; 21(3):294-304. PubMed ID: 32651974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CircRNA circRNA_102171 promotes papillary thyroid cancer progression through modulating CTNNBIP1-dependent activation of β-catenin pathway.
    Bi W; Huang J; Nie C; Liu B; He G; Han J; Pang R; Ding Z; Xu J; Zhang J
    J Exp Clin Cancer Res; 2018 Nov; 37(1):275. PubMed ID: 30424816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ETS like-1 protein ELK1-induced lncRNA LINC01638 accelerates the progression of papillary thyroid cancer by regulating Axin2 through Wnt/β-catenin signaling pathway.
    Lv P; Xue Y
    Bioengineered; 2021 Dec; 12(1):3873-3885. PubMed ID: 34281460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA PTCSC3/miR-574-5p Governs Cell Proliferation and Migration of Papillary Thyroid Carcinoma via Wnt/β-Catenin Signaling.
    Wang X; Lu X; Geng Z; Yang G; Shi Y
    J Cell Biochem; 2017 Dec; 118(12):4745-4752. PubMed ID: 28513866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZNRF3 is downregulated in papillary thyroid carcinoma and suppresses the proliferation and invasion of papillary thyroid cancer cells.
    Qiu W; Yang Z; Fan Y; Zheng Q
    Tumour Biol; 2016 Sep; 37(9):12665-12672. PubMed ID: 27448298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.